United States · Who invested in NeuSpera Medical?
NeuSpera Medical's investors include Treo Ventures, Vertex Ventures HC, Alumni Ventures, Vertex Ventures and Windham Capital Partners, and 2 more on record. Treo Ventures led its latest round.
United States · Series D startup
Who invested in NeuSpera Medical
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 1 round since 2024, from 2 sources
- Latest round
- Series D, $23MJul 2024
- Led by
- Treo Ventures and Vertex Ventures HC
- Investors
- 7 (2 led)
The rounds
- Jul 2024Series D$23M
Treo VenturesLead
Vertex Ventures HCLead
Alumni Ventures
Vertex Ventures
Windham Capital Partners
Action Potential Venture Capital- Olympus Innovation Ventures
Reported by Firms' own news pages and 1 other
Everyone who backed them
Olympus Innovation VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about NeuSpera Medical
How much has NeuSpera Medical raised?
NeuSpera Medical has raised $23M across 1 round since 2024.
When did NeuSpera Medical last raise?
NeuSpera Medical's most recent round was a Series D of $23M in Jul 2024, led by Treo Ventures.
What was NeuSpera Medical's biggest round?
Its most recent round, $23M in Jul 2024, is also its largest on record.
Who backed NeuSpera Medical first?
NeuSpera Medical's first round on record, in Jul 2024, was backed by Treo Ventures, Vertex Ventures HC and Alumni Ventures and 4 others.
What stage is NeuSpera Medical at?
NeuSpera Medical's latest named round is a Series D, in Jul 2024.
Where is NeuSpera Medical based?
NeuSpera Medical is based in the United States.
Who led NeuSpera Medical's rounds?
Treo Ventures led the Series D in 2024.
Companies like NeuSpera Medical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.